Potential Application of Curcumin and Its Analogues in the Treatment Strategy of Patients with Primary Epithelial Ovarian Cancer
出版年份 2014 全文链接
标题
Potential Application of Curcumin and Its Analogues in the Treatment Strategy of Patients with Primary Epithelial Ovarian Cancer
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 15, Issue 12, Pages 21703-21722
出版商
MDPI AG
发表日期
2014-11-26
DOI
10.3390/ijms151221703
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Induction of MicroRNA-9 Mediates Cytotoxicity of Curcumin Against SKOV3 Ovarian Cancer Cells
- (2014) Song-Feng Zhao et al. Asian Pacific Journal of Cancer Prevention
- Olaparib: a promising PARP inhibitor in ovarian cancer therapy
- (2013) Ying Chen et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Imaging and curcumin delivery in pancreatic cancer cell lines using PEGylated α-Gd2(MoO4)3mesoporous particles
- (2013) G. Seeta Rama Raju et al. DALTON TRANSACTIONS
- Antioxidants and cataract
- (2013) R. Thiagarajan et al. FREE RADICAL RESEARCH
- B19, a Novel Monocarbonyl Analogue of Curcumin, Induces Human Ovarian Cancer Cell Apoptosis via Activation of Endoplasmic Reticulum Stress and the Autophagy Signaling Pathway
- (2013) Wanglei Qu et al. International Journal of Biological Sciences
- Ovarian Cancer: In Search of Better Marker Systems Based on DNA Repair Defects
- (2013) Dominic Varga et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer
- (2013) R. Wendel Naumann et al. JOURNAL OF CLINICAL ONCOLOGY
- Aflibercept: A Novel VEGF Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Tumors
- (2013) Tina Sharma et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Effects and mechanisms of curcumin and basil polysaccharide on the invasion of SKOV3 cells and dendritic cells
- (2013) JING LV et al. Molecular Medicine Reports
- Safe and targeted anticancer therapy for ovarian cancer using a novel class of curcumin analogs
- (2013) Kellie S Rath et al. Journal of Ovarian Research
- Bevacizumab in the Treatment of Ovarian Cancer
- (2012) Florian Heitz et al. ADVANCES IN THERAPY
- Curcumin-From Molecule to Biological Function
- (2012) Tuba Esatbeyoglu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Prolonged Biologically Active Colonic Tissue Levels of Curcumin Achieved After Oral Administration--A Clinical Pilot Study Including Assessment of Patient Acceptability
- (2012) G. R. B. Irving et al. Cancer Prevention Research
- Multitargeting by turmeric, the golden spice: From kitchen to clinic
- (2012) Subash C. Gupta et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Biallelic Deleterious BRCA1 Mutations in a Woman with Early-Onset Ovarian Cancer
- (2012) Susan M. Domchek et al. Cancer Discovery
- Bevacizumab and ovarian cancer
- (2012) Agustin Garcia et al. Therapeutic Advances in Medical Oncology
- Optimizing Molecular-Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways
- (2012) Donavon Hiss Journal of Oncology
- Cellular uptake, retention and bioabsorption of HO-3867, a fluorinated curcumin analog with potential antitumor properties
- (2011) Alex Dayton et al. CANCER BIOLOGY & THERAPY
- HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition
- (2011) Karuppaiyah Selvendiran et al. CANCER BIOLOGY & THERAPY
- Essential Oil of Curcuma longa Inhibits Streptococcus mutans Biofilm Formation
- (2011) Kwang-Hee Lee et al. JOURNAL OF FOOD SCIENCE
- Synthesis of N-Substituted 3,5-Bis(arylidene)-4-piperidones with High Antitumor and Antioxidant Activity
- (2011) Tamás Kálai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Curcumin: An Anti-Inflammatory Molecule from a Curry Spice on the Path to Cancer Treatment
- (2011) Purusotam Basnet et al. MOLECULES
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase 3 Trial of Bevacizumab in Ovarian Cancer
- (2011) Timothy J. Perren et al. NEW ENGLAND JOURNAL OF MEDICINE
- A review of PARP inhibitors: from bench to bedside
- (2010) C. Underhill et al. ANNALS OF ONCOLOGY
- Curcumin in Cancer Chemoprevention: Molecular Targets, Pharmacokinetics, Bioavailability, and Clinical Trials
- (2010) Adeeb Shehzad et al. ARCHIV DER PHARMAZIE
- The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation
- (2010) Chandana Mohanty et al. BIOMATERIALS
- Curcumin polymers as anticancer conjugates
- (2010) Huadong Tang et al. BIOMATERIALS
- Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer
- (2010) Mathilde Bayet-Robert et al. CANCER BIOLOGY & THERAPY
- Farletuzumab in epithelial ovarian carcinoma
- (2010) Whitney A Spannuth et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Safe and targeted anticancer efficacy of a novel class of antioxidant-conjugated difluorodiarylidenyl piperidones: Differential cytotoxicity in healthy and cancer cells
- (2010) Karuppaiyah Selvendiran et al. FREE RADICAL BIOLOGY AND MEDICINE
- How to kill tumor cells with inhibitors of poly(ADP-ribosyl)ation
- (2010) Aswin Mangerich et al. INTERNATIONAL JOURNAL OF CANCER
- Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses inBRCACarrier Ovarian Cancer Correlating With Platinum-Free Interval
- (2010) Peter C. Fong et al. JOURNAL OF CLINICAL ONCOLOGY
- Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells
- (2010) Murali Mohan Yallapu et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- Curcumin Enhances Oral Bioavailability and Anti-Tumor Therapeutic Efficacy of Paclitaxel upon Administration in Nanoemulsion Formulation
- (2010) Srinivas Ganta et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial
- (2010) Gordon JS Rustin et al. LANCET
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
- (2010) M William Audeh et al. LANCET
- HO-3867, a Synthetic Compound, Inhibits the Migration and Invasion of Ovarian Carcinoma Cells through Downregulation of Fatty Acid Synthase and Focal Adhesion Kinase
- (2010) K. Selvendiran et al. MOLECULAR CANCER RESEARCH
- Anticancer Efficacy of a Difluorodiarylidenyl Piperidone (HO-3867) in Human Ovarian Cancer Cells and Tumor Xenografts
- (2010) K. Selvendiran et al. MOLECULAR CANCER THERAPEUTICS
- Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth
- (2010) Murali M Yallapu et al. Journal of Ovarian Research
- Synthesis, cytotoxic and combined cDDP activity of new stable curcumin derivatives
- (2009) Erika Ferrari et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Lysophosphatidic acid induces STAT3 phosphorylation and ovarian cancer cell motility: Their inhibition by curcumin
- (2009) Ji Hye Seo et al. CANCER LETTERS
- Cell-cycle inhibition and apoptosis induced by curcumin and cisplatin or oxaliplatin in human ovarian carcinoma cells
- (2009) M. Montopoli et al. CELL PROLIFERATION
- A randomised, double-blind, phase II study of two doses of pemetrexed in the treatment of platinum-resistant, epithelial ovarian or primary peritoneal cancer
- (2009) Ignace Vergote et al. EUROPEAN JOURNAL OF CANCER
- CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis
- (2009) Marianne Boivin et al. GYNECOLOGIC ONCOLOGY
- Coadministration of Paclitaxel and Curcumin in Nanoemulsion Formulations To Overcome Multidrug Resistance in Tumor Cells
- (2009) Srinivas Ganta et al. MOLECULAR PHARMACEUTICS
- Mucins in ovarian cancer diagnosis and therapy
- (2009) Subhash C Chauhan et al. Journal of Ovarian Research
- Antiangiogenic drugs in ovarian cancer
- (2008) G C Kumaran et al. BRITISH JOURNAL OF CANCER
- Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells
- (2008) Chao Ji et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Pharmacokinetics of Curcumin Conjugate Metabolites in Healthy Human Subjects
- (2008) S. K. Vareed et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Secondary BRCA1 Mutations in BRCA1-Mutated Ovarian Carcinomas with Platinum Resistance
- (2008) E. M. Swisher et al. CANCER RESEARCH
- Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer
- (2008) N. Dhillon et al. CLINICAL CANCER RESEARCH
- Curcumin in cancer management: Recent results of analogue design and clinical studies and desirable future research
- (2008) William P. Steward et al. MOLECULAR NUTRITION & FOOD RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started